Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.3 trillion and total revenue of $116.09 billion.
Market Cap
1.3T
Revenue
116.09B
Profits
-38.16B
PE Ratio
n/a
Profit Margin
-32.88%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 128.84B | -1.55% | 2,434,825 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.37B | -0.58% | 2,466,999 | 15.53B |
| 3 | ARGX | argenx SE | 62.49B | -0.55% | 244,020 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 61.50B | -2.55% | 20,238,546 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.93B | -3.04% | 5,919,097 | - |
| 6 | ONC | BeOne Medicines AG | 39.89B | -0.74% | 438,375 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.59B | -0.88% | 7,086,011 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.06B | -2.42% | 2,756,176 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.73B | -0.53% | 32,176,044 | 7.53M |
| 10 | INSM | Insmed Incorporated | 26.21B | -3.21% | 3,444,901 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.40B | -1.81% | 3,700,367 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.13B | -2.64% | 1,195,339 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.72B | 0.58% | 2,711,560 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.63B | -1.27% | 2,214,107 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 15.55B | -0.97% | 1,558,665 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.46B | -0.22% | 5,243,352 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 14.24B | 0.73% | 13,036,319 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.02B | -1.04% | 4,103,365 | 713.07M |
| 19 | HALO | Halozyme Therapeutics, Inc. | 12.76B | 2.53% | 10,347,741 | 1.66B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 12.38B | -1.75% | 4,455,803 | 3.41B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.28B | -0.54% | 330,581 | 1.28B |
| 22 | CORT | Corcept Therapeutics Incorporated | 11.92B | -3.98% | 17,233,433 | 830.81M |
| 23 | TECH | Bio-Techne Corporation | 11.35B | -0.06% | 5,019,523 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 10.88B | -3.03% | 846,277 | 776.57M |
| 25 | TWST | Twist Bioscience Corporation | 10.47B | 7.35% | 3,073,294 | 431.80M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.97B | -0.61% | 1,003,942 | 440.48M |
| 27 | KYMR | Kymera Therapeutics, Inc. | 9.79B | -0.62% | 1,900,262 | 105.00M |
| 28 | CYTK | Cytokinetics, Incorporated | 9.56B | -1.63% | 4,872,967 | 67.67M |
| 29 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.39B | -1.86% | 4,016,375 | 669.50M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.25B | -0.49% | 1,833,723 | 281.99M |
| 31 | ABVX | ABIVAX Société Anonyme | 9.10B | -1.82% | 876,004 | 5.67M |
| 32 | IBRX | ImmunityBio, Inc. | 8.99B | 0.24% | 18,441,256 | 165.79M |
| 33 | PCVX | Vaxcyte, Inc. | 8.65B | -3.71% | 2,709,997 | - |
| 34 | CAI | Caris Life Sciences, Inc. | 8.47B | -3.04% | 14,723,087 | 989.61M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.35B | -3.71% | 827,205 | 7.46M |
| 36 | TGTX | TG Therapeutics, Inc. | 8.07B | 0.71% | 5,168,987 | 799.54M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.96B | -2.62% | 3,357,063 | - |
| 38 | IMVT | Immunovant, Inc. | 7.63B | -1.86% | 2,943,784 | - |
| 39 | IONS | Ionis Pharmaceuticals, Inc. | 7.39B | -4.94% | 7,369,359 | 874.09M |
| 40 | BLTE | Belite Bio, Inc | 6.88B | 0.36% | 93,894 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.73B | -1.32% | 1,123,069 | 239.92M |
| 42 | CGON | CG Oncology, Inc. | 6.61B | -1.32% | 1,779,212 | 6.23M |
| 43 | ORKA | Oruka Therapeutics, Inc. | 6.29B | -2.83% | 1,943,005 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.96B | -7.07% | 1,797,929 | 618.07M |
| 45 | TVTX | Travere Therapeutics, Inc. | 5.92B | -3.06% | 2,235,840 | 591.33M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.68B | -4.83% | 3,253,088 | - |
| 47 | LGND | Ligand Pharmaceuticals Incorporated | 5.65B | -0.43% | 372,798 | 290.54M |
| 48 | CRSP | CRISPR Therapeutics AG | 5.47B | -1.34% | 3,382,855 | 13.39M |
| 49 | COGT | Cogent Biosciences, Inc. | 5.47B | -5.09% | 4,604,051 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.46B | -3.87% | 3,853,343 | 1.01B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.42B | -4.26% | 2,829,339 | 1.90M |
| 52 | DFTX | Definium Therapeutics, Inc. | 5.21B | 0.34% | 3,215,132 | - |
| 53 | ERAS | Erasca, Inc. | 5.17B | -3.72% | 8,687,362 | - |
| 54 | PBLS | Parabilis Medicines, Inc. | 5.16B | 2.08% | 9,085,998 | 148.00K |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.92B | -3.45% | 1,991,848 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.70B | -0.58% | 5,482,809 | 1.14B |
| 57 | IOVA | Iovance Biotherapeutics, Inc. | 4.64B | 2.30% | 22,879,404 | 324.97M |
| 58 | MANE | Veradermics, Incorporated | 4.46B | -1.78% | 1,869,214 | - |
| 59 | TLX | Telix Pharmaceuticals Limited | 4.31B | 0.64% | 187,385 | 890.79M |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.13B | -1.82% | 10,063,128 | 10.35M |
| 61 | ABCL | AbCellera Biologics Inc. | 4.09B | -0.79% | 5,438,252 | 66.17M |
| 62 | CELC | Celcuity Inc. | 3.94B | -5.06% | 1,406,089 | - |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.85B | -30.69% | 17,948,749 | 7.50M |
| 64 | IDYA | IDEAYA Biosciences, Inc. | 3.71B | -0.52% | 2,492,498 | 234.13M |
| 65 | TNGX | Tango Therapeutics, Inc. | 3.67B | -7.41% | 6,243,030 | 53.81M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.62B | -1.57% | 6,005,800 | - |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 3.43B | -1.19% | 710,964 | 606.33M |
| 68 | LEGN | Legend Biotech Corporation | 3.41B | 0.17% | 2,937,734 | 1.27B |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.38B | -1.26% | 2,671,391 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.21B | -1.17% | 2,897,085 | 117.00M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.20B | -5.26% | 4,849,526 | - |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.19B | -4.08% | 19,137,064 | 463.98M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.15B | -2.04% | 2,956,193 | 3.60M |
| 74 | QURE | uniQure N.V. | 3.05B | -0.20% | 2,096,230 | 18.67M |
| 75 | MBX | MBX Biosciences, Inc. | 3.03B | -1.53% | 932,291 | - |
| 76 | CLDX | Celldex Therapeutics, Inc. | 3.00B | -1.90% | 2,081,878 | 158.00K |
| 77 | ZLAB | Zai Lab Limited | 2.89B | -0.43% | 887,483 | 449.61M |
| 78 | PGEN | Precigen, Inc. | 2.79B | -1.14% | 9,552,894 | 85.72M |
| 79 | IMNM | Immunome, Inc. | 2.72B | 0.17% | 3,962,925 | 4.02M |
| 80 | NAMS | NewAmsterdam Pharma Company N.V. | 2.69B | 2.55% | 2,076,381 | 7.12M |
| 81 | IRON | Disc Medicine, Inc. | 2.67B | 0.51% | 1,077,129 | - |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.64B | -0.24% | 2,839,480 | 36.77M |
| 83 | PHVS | Pharvaris N.V. | 2.55B | -4.29% | 578,450 | - |
| 84 | GPCR | Structure Therapeutics Inc. | 2.50B | -0.28% | 1,547,961 | - |
| 85 | BEAM | Beam Therapeutics Inc. | 2.49B | 1.13% | 2,288,213 | 156.04M |
| 86 | VRDN | Viridian Therapeutics, Inc. | 2.49B | 0.32% | 5,381,481 | 71.13M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | 0.14% | 3,786,935 | - |
| 88 | VERA | Vera Therapeutics, Inc. | 2.45B | -0.79% | 4,191,072 | - |
| 89 | HRMY | Harmony Biosciences Holdings, Inc. | 2.45B | -1.68% | 3,820,452 | 959.90M |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.32B | -0.35% | 14,575,346 | - |
| 91 | NKTR | Nektar Therapeutics | 2.29B | -1.84% | 2,806,719 | 54.59M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.25B | -0.35% | 1,198,252 | 311.51M |
| 93 | GENB | Generate Biomedicines, Inc. | 2.20B | 0.12% | 1,404,406 | 26.48M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.19B | -1.48% | 4,100,927 | 52.06M |
| 95 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -2.44% | 644,540 | - |
| 96 | TRVI | Trevi Therapeutics, Inc. | 2.13B | -1.71% | 2,138,487 | - |
| 97 | SRPT | Sarepta Therapeutics, Inc. | 2.12B | -2.71% | 6,292,411 | 1.97B |
| 98 | URGN | UroGen Pharma Ltd. | 2.11B | -1.59% | 703,070 | 188.73M |
| 99 | BHVN | Biohaven Ltd. | 2.06B | -1.94% | 6,431,843 | - |
| 100 | NUVB | Nuvation Bio Inc. | 2.05B | -3.62% | 4,434,708 | 169.90M |
| 101 | RXRX | Recursion Pharmaceuticals, Inc. | 2.05B | 8.19% | 44,032,351 | 54.86M |
| 102 | ZBIO | Zenas BioPharma, Inc. | 2.05B | -1.47% | 2,514,836 | 1.00M |
| 103 | KOD | Kodiak Sciences Inc. | 2.05B | -0.43% | 1,608,940 | - |
| 104 | VCEL | Vericel Corporation | 2.05B | -0.02% | 1,126,472 | 306.30M |
| 105 | ADMA | ADMA Biologics, Inc. | 2.04B | 1.79% | 11,401,381 | 512.28M |
| 106 | AGIO | Agios Pharmaceuticals, Inc. | 1.97B | -1.61% | 1,566,176 | 98.34M |
| 107 | MESO | Mesoblast Limited | 1.95B | 1.75% | 215,702 | 120.25M |
| 108 | RAPP | Rapport Therapeutics, Inc. | 1.94B | -3.58% | 996,598 | 20.00M |
| 109 | GHRS | GH Research PLC | 1.94B | -1.60% | 132,821 | - |
| 110 | COAG | Hemab Therapeutics Holdings, Inc. | 1.92B | -0.07% | 4,149,492 | - |
| 111 | FTRE | Fortrea Holdings Inc. | 1.90B | -1.73% | 3,107,457 | 2.68B |
| 112 | ZYME | Zymeworks Inc. | 1.89B | -3.31% | 1,096,077 | 37.13M |
| 113 | BRVE | Braveheart Bio, Inc. | 1.87B | 5.38% | 2,017,785 | - |
| 114 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -1.25% | 459,091 | 1.13B |
| 115 | XNCR | Xencor, Inc. | 1.84B | 0.53% | 5,207,445 | 104.97M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.83B | -1.73% | 1,560,344 | 27.59M |
| 117 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.81B | -4.13% | 2,518,413 | 208.78M |
| 118 | SEPN | Septerna, Inc. | 1.81B | -2.05% | 445,395 | 98.88M |
| 119 | VIR | Vir Biotechnology, Inc. | 1.79B | -2.93% | 7,017,419 | 303.23M |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.77B | 5.32% | 2,069,682 | - |
| 121 | NBTX | Nanobiotix S.A. | 1.74B | -7.92% | 149,343 | 38.27M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.70B | -0.98% | 8,626,249 | 59.51M |
| 123 | NVAX | Novavax, Inc. | 1.67B | 1.10% | 11,145,562 | 413.80M |
| 124 | KLRA | Kailera Therapeutics, Inc. | 1.66B | -0.70% | 3,164,345 | - |
| 125 | ABSI | Absci Corporation | 1.66B | 4.10% | 7,732,761 | 1.56M |
| 126 | IMCR | Immunocore Holdings plc | 1.65B | -0.93% | 475,903 | 430.78M |
| 127 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | -2.71% | 9,116,676 | 5.49M |
| 128 | ANAB | AnaptysBio, Inc. | 1.63B | 0.25% | 868,842 | 232.39M |
| 129 | INBX | Inhibrx Biosciences, Inc. | 1.61B | 4.41% | 483,373 | 1.30M |
| 130 | KRSA | Korsana Biosciences, Inc. | 1.59B | 3.77% | 33,889 | - |
| 131 | SNDX | Syndax Pharmaceuticals, Inc. | 1.57B | -0.34% | 5,166,443 | 252.25M |
| 132 | KARD | Kardigan, Inc. | 1.56B | -0.30% | 6,566,538 | - |
| 133 | INVA | Innoviva, Inc. | 1.53B | 0.43% | 1,437,017 | 440.00M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.50B | 0.22% | 934,225 | - |
| 135 | LTGO | Latigo Biotherapeutics, Inc. | 1.50B | -5.77% | 1,488,100 | - |
| 136 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | 0.07% | 13,312,300 | 717.00M |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 1.90% | 1,238,530 | - |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.41B | -1.61% | 624,233 | - |
| 139 | AVLN | Avalyn Pharma Inc. | 1.40B | -5.71% | 664,783 | - |
| 140 | DMRA | Damora Therapeutics, Inc. | 1.39B | -0.83% | 3,316,841 | - |
| 141 | AAPG | Ascentage Pharma Group International | 1.39B | -2.02% | 2,066 | 94.61M |
| 142 | TRAX | First Tracks Biotherapeutics, Inc. | 1.38B | -1.53% | 2,590,714 | - |
| 143 | LBRX | LB Pharmaceuticals Inc | 1.37B | 0.78% | 531,640 | - |
| 144 | SVRA | Savara Inc. | 1.36B | -0.92% | 2,181,824 | - |
| 145 | CGEM | Cullinan Therapeutics, Inc. | 1.36B | -1.31% | 3,250,998 | - |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.33B | -0.70% | 3,090,943 | - |
| 147 | OMER | Omeros Corporation | 1.29B | -3.14% | 2,151,811 | 38.42M |
| 148 | MGTX | MeiraGTx Holdings plc | 1.27B | 1.53% | 941,178 | 397.50M |
| 149 | VOR | Vor Biopharma Inc. | 1.27B | -2.24% | 3,725,696 | - |
| 150 | MAZE | Maze Therapeutics, Inc. | 1.25B | -3.92% | 1,494,806 | 20.00M |
| 151 | REPL | Replimune Group, Inc. | 1.23B | 1.55% | 2,143,525 | - |
| 152 | AKTS | Aktis Oncology, Inc. | 1.22B | -4.29% | 2,729,349 | 10.06M |
| 153 | APMD | Apnimed, Inc. | 1.21B | 3.17% | 3,141,754 | 115.12M |
| 154 | ANRO | Alto Neuroscience, Inc. | 1.19B | -2.29% | 2,199,282 | - |
| 155 | IMTX | Immatics N.V. | 1.18B | -2.27% | 759,924 | 47.65M |
| 156 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | 5.00% | 2,604,196 | 99.00K |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.15B | -1.97% | 2,177,340 | - |
| 158 | MNKD | MannKind Corporation | 1.14B | -1.12% | 5,513,378 | 393.63M |
| 159 | OBX | Obsidian Therapeutics, Inc. | 1.10B | 1.43% | 3,974,349 | - |
| 160 | JBIO | Jade Biosciences, Inc. | 1.08B | -1.17% | 2,942,224 | - |
| 161 | CRVS | Corvus Pharmaceuticals, Inc. | 1.06B | 0.08% | 4,460,676 | - |
| 162 | MLTX | MoonLake Immunotherapeutics | 1.05B | 0.32% | 1,803,353 | - |
| 163 | KURA | Kura Oncology, Inc. | 1.04B | 0.09% | 2,665,262 | 77.23M |
| 164 | GLUE | Monte Rosa Therapeutics, Inc. | 1.03B | -3.73% | 1,598,224 | 28.73M |
| 165 | JANX | Janux Therapeutics, Inc. | 1.01B | -1.60% | 2,447,399 | 24.00M |
| 166 | ANL | Adlai Nortye Group Ltd. | 1.01B | 3.01% | 156,607 | 18.06M |
| 167 | ATTO | Attovia Therapeutics, Inc. | 1.01B | -2.60% | 1,361,380 | 1.80M |
| 168 | ALMS | Alumis Inc. | 1.01B | -0.64% | 6,393,054 | 7.40M |
| 169 | ABUS | Arbutus Biopharma Corporation | 991.22M | -1.18% | 6,458,403 | 181.72M |
| 170 | SLBT | SL Science Holding Limited | 980.86M | -8.02% | 60,445 | 3.27M |
| 171 | SGP | SpyGlass Pharma, Inc. | 972.67M | -0.85% | 608,049 | - |
| 172 | SLDB | Solid Biosciences Inc. | 955.38M | 0.45% | 4,074,139 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 928.02M | - | 7,380,873 | - |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 912.16M | 0.74% | 7,458,732 | 41.47M |
| 175 | HELP | Cybin Inc. | 903.75M | -11.77% | 5,666,919 | - |
| 176 | IMMX | Immix Biopharma, Inc. | 894.24M | -1.73% | 4,183,905 | - |
| 177 | FTH | Faeth Therapeutics, Inc. | 891.49M | -1.79% | 2,197,796 | - |
| 178 | AVTX | Avalo Therapeutics, Inc. | 888.65M | -0.72% | 3,233,360 | 59.00K |
| 179 | TBPH | Theravance Biopharma, Inc. | 883.66M | -0.12% | 683,738 | 104.31M |
| 180 | IVA | Inventiva S.A. | 875.21M | 0.80% | 1,045,417 | 7.94M |
| 181 | RIGL | Rigel Pharmaceuticals, Inc. | 871.23M | 1.72% | 924,916 | 276.79M |
| 182 | OLMA | Olema Pharmaceuticals, Inc. | 859.23M | -0.81% | 3,061,450 | - |
| 183 | WVE | Wave Life Sciences, Inc. | 857.16M | -2.03% | 4,410,450 | 65.37M |
| 184 | ARDX | Ardelyx, Inc. | 852.22M | 1.18% | 6,442,911 | 450.89M |
| 185 | FDMT | 4D Molecular Therapeutics, Inc. | 840.82M | 3.68% | 1,787,705 | 92.01M |
| 186 | GERN | Geron Corporation | 835.22M | -1.52% | 17,244,669 | 204.56M |
| 187 | ETRA | Electra Therapeutics, Inc. | 831.66M | -11.67% | 5,124,319 | - |
| 188 | CADL | Candel Therapeutics, Inc. | 830.23M | -4.32% | 3,014,504 | - |
| 189 | ACHV | Achieve Life Sciences, Inc. | 821.16M | 0.88% | 2,830,227 | - |
| 190 | ACRS | Aclaris Therapeutics, Inc. | 809.59M | 1.85% | 4,687,999 | 8.22M |
| 191 | CLYM | Climb Bio, Inc. | 806.98M | -0.07% | 4,049,705 | - |
| 192 | ANNX | Annexon, Inc. | 801.92M | 1.44% | 4,940,247 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 800.55M | 5.15% | 1,203,802 | 109.82M |
| 194 | BLSM | BlossomHill Therapeutics, Inc. | 788.77M | -4.03% | 715,108 | - |
| 195 | DSGN | Design Therapeutics, Inc. | 766.00M | -4.45% | 2,554,901 | - |
| 196 | PHAR | Pharming Group N.V. | 744.14M | -2.13% | 7,848 | 366.48M |
| 197 | SLN | Silence Therapeutics plc | 734.55M | -3.94% | 1,140,612 | 615.00K |
| 198 | DBVT | DBV Technologies S.A. | 729.61M | -1.28% | 137,640 | 5.04M |
| 199 | CBIO | Crescent Biopharma, Inc. | 722.91M | 0.72% | 3,123,507 | 11.88M |
| 200 | NVCT | Nuvectis Pharma, Inc. | 716.79M | 2.90% | 880,109 | - |
| 201 | MDXG | MiMedx Group, Inc. | 695.28M | 1.71% | 3,904,752 | 355.17M |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 689.45M | -1.94% | 1,481,693 | 136.07M |
| 203 | SGMT | Sagimet Biosciences Inc. | 689.34M | -0.72% | 1,847,480 | - |
| 204 | VSTM | Verastem, Inc. | 673.79M | -1.46% | 4,497,074 | 87.53M |
| 205 | AURA | Aura Biosciences, Inc. | 667.86M | -2.28% | 3,776,728 | - |
| 206 | OABI | OmniAb, Inc. | 649.90M | 0.68% | 1,862,280 | 38.46M |
| 207 | MNPR | Monopar Therapeutics Inc. | 647.52M | -6.07% | 382,774 | - |
| 208 | NGNE | Neurogene Inc. | 642.17M | -0.99% | 1,388,786 | 925.00K |
| 209 | ALT | Altimmune, Inc. | 632.18M | 0.31% | 12,176,810 | 31.00K |
| 210 | OCS | Oculis Holding AG | 625.96M | 1.60% | 412,068 | 1.45M |
| 211 | SCTX | Scribe Therapeutics Inc. | 624.75M | 2.68% | 2,234,321 | 33.30M |
| 212 | VALN | Valneva SE | 608.96M | -0.30% | 42,214 | 163.30M |
| 213 | MPLT | MapLight Therapeutics, Inc. | 606.89M | -3.53% | 1,832,868 | - |
| 214 | STTK | Shattuck Labs, Inc. | 603.18M | 2.74% | 7,399,989 | 1.00M |
| 215 | DRUG | Bright Minds Biosciences Inc. | 602.76M | -0.93% | 142,382 | - |
| 216 | CRMD | CorMedix Inc. | 601.73M | -0.90% | 1,806,366 | 462.25M |
| 217 | CTMX | CytomX Therapeutics, Inc. | 601.40M | -2.13% | 9,598,348 | 18.30M |
| 218 | AGMB | AgomAb Therapeutics NV | 599.35M | 0.75% | 250,673 | - |
| 219 | PHAT | Phathom Pharmaceuticals, Inc. | 594.14M | -3.48% | 1,783,598 | 239.66M |
| 220 | ALLO | Allogene Therapeutics, Inc. | 583.88M | -2.31% | 12,716,730 | 4.64M |
| 221 | PROK | ProKidney Corp. | 577.44M | 6.11% | 9,447,040 | 818.00K |
| 222 | EPRX | Eupraxia Pharmaceuticals Inc. | 563.16M | 2.39% | 553,548 | - |
| 223 | PRME | Prime Medicine, Inc. | 555.06M | -0.64% | 4,659,594 | 4.07M |
| 224 | ARVN | Arvinas, Inc. | 542.05M | -0.24% | 1,775,939 | 316.70M |
| 225 | DNA | Ginkgo Bioworks Holdings, Inc. | 530.64M | 0.51% | 1,763,042 | 132.42M |
| 226 | RGNX | REGENXBIO Inc. | 530.09M | -2.31% | 3,369,893 | 174.48M |
| 227 | TECX | Tectonic Therapeutic, Inc. | 527.83M | -0.77% | 330,585 | - |
| 228 | CAPR | Capricor Therapeutics, Inc. | 526.74M | -3.82% | 3,255,709 | 11.13M |
| 229 | OVID | Ovid Therapeutics Inc. | 525.35M | -0.37% | 5,899,295 | 1.58M |
| 230 | AUTL | Autolus Therapeutics plc | 516.36M | 1.04% | 1,769,812 | 117.39M |
| 231 | ENTX | Entera Bio Ltd. | 512.50M | -2.31% | 288,961 | 42.00K |
| 232 | CTNM | Contineum Therapeutics, Inc. | 509.01M | 2.42% | 2,139,449 | - |
| 233 | ASMB | Assembly Biosciences, Inc. | 508.40M | -1.46% | 1,413,892 | 74.85M |
| 234 | PRLD | Prelude Therapeutics Incorporated | 501.59M | 6.56% | 1,162,739 | 22.42M |
| 235 | PBYI | Puma Biotechnology, Inc. | 495.55M | 0.84% | 326,966 | 231.24M |
| 236 | EIKN | Eikon Therapeutics, Inc. | 484.78M | 4.07% | 2,242,512 | - |
| 237 | VOGX | Vogenx, Inc. | 482.79M | -4.78% | 507,463 | - |
| 238 | INDP | Indaptus Therapeutics, Inc. | 473.01M | -9.67% | 1,163,430 | - |
| 239 | ARCT | Arcturus Therapeutics Holdings Inc. | 455.62M | -5.32% | 841,464 | 29.37M |
| 240 | TTRX | Turn Therapeutics Inc. | 445.03M | 8.10% | 929,716 | - |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 440.94M | 1.28% | 961,253 | - |
| 242 | PRTA | Prothena Corporation plc | 440.47M | 1.42% | 1,828,400 | 54.53M |
| 243 | RLMD | Relmada Therapeutics, Inc. | 439.48M | -1.90% | 2,064,067 | - |
| 244 | CABA | Cabaletta Bio, Inc. | 432.34M | -1.16% | 12,484,814 | - |
| 245 | IRD | Opus Genetics, Inc. | 430.95M | -1.89% | 5,543,229 | 9.86M |
| 246 | AVIR | Atea Pharmaceuticals, Inc. | 427.49M | 1.33% | 600,436 | - |
| 247 | ZURA | Zura Bio Limited | 427.40M | -2.41% | 1,661,806 | - |
| 248 | ARTV | Artiva Biotherapeutics, Inc. | 420.94M | 2.01% | 2,208,254 | 251.00K |
| 249 | IKT | Inhibikase Therapeutics, Inc. | 418.77M | - | 3,209,727 | 1.00 |
| 250 | CCCC | C4 Therapeutics, Inc. | 417.06M | -0.73% | 1,630,885 | 35.04M |
| 251 | EDIT | Editas Medicine, Inc. | 414.67M | -0.74% | 17,031,531 | 47.01M |
| 252 | SPRY | ARS Pharmaceuticals, Inc. | 408.73M | -0.96% | 1,882,252 | 116.93M |
| 253 | RZLT | Rezolute, Inc. | 401.15M | -2.78% | 2,517,599 | - |
| 254 | LRMR | Larimar Therapeutics, Inc. | 395.61M | -0.26% | 1,641,201 | - |
| 255 | VTVT | vTv Therapeutics Inc. | 395.11M | 1.27% | 74,370 | 36.84M |
| 256 | GALT | Galectin Therapeutics Inc. | 392.31M | 4.85% | 1,065,892 | - |
| 257 | BNTC | Benitec Biopharma Inc. | 384.41M | -2.99% | 422,989 | - |
| 258 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 382.43M | -2.45% | 1,229,844 | - |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 372.41M | -1.48% | 126,304 | 59.22M |
| 260 | RCKT | Rocket Pharmaceuticals, Inc. | 369.94M | -3.71% | 1,593,378 | - |
| 261 | DMAC | DiaMedica Therapeutics Inc. | 369.39M | - | 194,955 | - |
| 262 | OBIO | Orchestra BioMed Holdings, Inc. | 365.44M | 5.19% | 1,138,353 | 31.98M |
| 263 | OCGN | Ocugen, Inc. | 359.46M | 2.91% | 14,758,161 | 4.58M |
| 264 | ENTA | Enanta Pharmaceuticals, Inc. | 355.33M | -2.56% | 428,232 | 65.26M |
| 265 | XFOR | X4 Pharmaceuticals, Inc. | 354.95M | 2.29% | 1,543,427 | 15.85M |
| 266 | AGEN | Agenus Inc. | 353.41M | 8.73% | 2,084,681 | 132.69M |
| 267 | EVMN | Evommune, Inc. | 350.22M | 2.99% | 1,493,967 | 10.00M |
| 268 | LXEO | Lexeo Therapeutics, Inc. | 344.58M | 0.48% | 2,287,770 | - |
| 269 | CMPX | Compass Therapeutics, Inc. | 342.17M | 2.70% | 8,210,029 | 850.00K |
| 270 | IPSC | Century Therapeutics, Inc. | 336.80M | -1.06% | 1,369,353 | 109.16M |
| 271 | EYPT | EyePoint, Inc. | 331.92M | -3.51% | 7,266,552 | 2.79M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 319.36M | 0.29% | 1,960,632 | 114.70K |
| 273 | ABEO | Abeona Therapeutics Inc. | 318.51M | -0.36% | 2,772,456 | 25.52M |
| 274 | QTTB | Q32 Bio Inc. | 313.77M | -2.95% | 968,986 | 53.74M |
| 275 | VNDA | Vanda Pharmaceuticals Inc. | 310.17M | 0.39% | 1,658,565 | 215.72M |
| 276 | IFRX | InflaRx N.V. | 308.00M | 1.46% | 292,162 | -11.54K |
| 277 | FATE | Fate Therapeutics, Inc. | 303.15M | 0.40% | 4,186,735 | 6.49M |
| 278 | CUVL | Clinuvel Pharmaceuticals Limited | 300.05M | 2.05% | 14,556 | 65.05M |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 294.43M | 0.97% | 1,259,913 | 26.87M |
| 280 | UPB | Upstream Bio, Inc. | 292.48M | 0.56% | 1,000,956 | 3.16M |
| 281 | IMRX | Immuneering Corporation | 289.84M | 0.45% | 1,077,823 | - |
| 282 | VCRE | Vicore Pharma Holding AB (publ) | 288.30M | 0.29% | 27,092 | 412.09K |
| 283 | FULC | Fulcrum Therapeutics, Inc. | 286.88M | -0.27% | 3,656,213 | 80.00M |
| 284 | GLSI | Greenwich LifeSciences, Inc. | 278.74M | 3.26% | 302,252 | - |
| 285 | PYXS | Pyxis Oncology, Inc. | 277.75M | -2.35% | 561,045 | 11.04M |
| 286 | PALI | Palisade Bio, Inc. | 277.09M | -6.47% | 6,872,526 | 500.00K |
| 287 | YARW | Yarrow Bioscience, Inc. | 273.64M | -3.83% | 156,504 | - |
| 288 | LYEL | Lyell Immunopharma, Inc. | 269.80M | 1.94% | 401,120 | 27.00K |
| 289 | SION | Sionna Therapeutics, Inc. | 269.47M | -16.99% | 3,699,843 | - |
| 290 | CUE | Cue Biopharma, Inc. | 269.15M | -2.09% | 381,737 | 37.66M |
| 291 | CAMP | Camp4 Therapeutics Corporation | 266.07M | 5.21% | 1,043,108 | 4.22M |
| 292 | MGNX | MacroGenics, Inc. | 263.72M | 0.24% | 873,936 | 175.14M |
| 293 | ACIU | AC Immune SA | 261.49M | -1.87% | 68,459 | 21.67M |
| 294 | LCTX | Lineage Cell Therapeutics, Inc. | 260.49M | - | 3,209,250 | 13.08M |
| 295 | PRQR | ProQR Therapeutics N.V. | 258.25M | -3.17% | 569,287 | 21.05M |
| 296 | BCYC | Bicycle Therapeutics plc | 255.47M | -0.82% | 240,418 | 61.21M |
| 297 | STRO | Sutro Biopharma, Inc. | 254.36M | -0.90% | 651,368 | 45.70M |
| 298 | FHTX | Foghorn Therapeutics Inc. | 245.86M | -1.43% | 501,994 | 36.74M |
| 299 | TRDA | Entrada Therapeutics, Inc. | 243.38M | -2.17% | 354,430 | 4.69M |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 242.95M | 2.16% | 211,130 | 1.48M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 239.44M | 2.94% | 1,972,036 | 7.15M |
| 302 | CGEN | Compugen Ltd. | 235.86M | 1.22% | 128,001 | 74.00M |
| 303 | ALXO | ALX Oncology Holdings Inc. | 235.07M | -2.30% | 5,063,196 | - |
| 304 | AVXL | Anavex Life Sciences Corp. | 224.33M | 0.41% | 920,484 | - |
| 305 | YDES | YD Bio Limited | 224.32M | -1.54% | 535,517 | 1.24M |
| 306 | IVVD | Invivyd, Inc. | 222.63M | 1.22% | 6,277,679 | 58.37M |
| 307 | ADAG | Adagene Inc. | 222.24M | -1.78% | 286,984 | 9.29M |
| 308 | KROS | Keros Therapeutics, Inc. | 221.87M | -1.50% | 302,418 | 15.01M |
| 309 | NGEN | NervGen Pharma Corp. | 220.42M | -9.69% | 608,534 | - |
| 310 | PLX | Protalix BioTherapeutics, Inc. | 216.74M | -0.37% | 1,249,529 | 80.62M |
| 311 | ALEC | Alector, Inc. | 213.26M | 3.24% | 2,119,028 | 13.86M |
| 312 | ELDN | Eledon Pharmaceuticals, Inc. | 213.11M | -1.13% | 828,607 | - |
| 313 | TARA | Protara Therapeutics, Inc. | 209.79M | -4.05% | 3,945,662 | - |
| 314 | VRXA | Veraxa Biotech AG | 208.58M | 0.34% | 16,375 | 29.54K |
| 315 | CHRS | Coherus Oncology, Inc. | 208.58M | 9.76% | 3,124,885 | 50.94M |
| 316 | NKTX | Nkarta, Inc. | 202.70M | 0.71% | 609,732 | - |
| 317 | PEPG | PepGen Inc. | 197.39M | -4.04% | 578,987 | - |
| 318 | MSLE | Satellos Bioscience Inc. | 197.34M | -3.72% | 19,814 | - |
| 319 | ORMP | Oramed Pharmaceuticals Inc. | 197.17M | 1.50% | 806,106 | 2.00M |
| 320 | SLGL | Sol-Gel Technologies Ltd. | 196.44M | -7.03% | 45,610 | 1.80M |
| 321 | SRZN | Surrozen, Inc. | 194.52M | -2.30% | 190,168 | 11.51M |
| 322 | ACOG | Alpha Cognition Inc. | 192.52M | -0.11% | 61,875 | 15.26M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 191.64M | 3.11% | 890,159 | - |
| 324 | ANTX | AN2 Therapeutics, Inc. | 190.57M | 3.06% | 670,953 | - |
| 325 | VYGR | Voyager Therapeutics, Inc. | 190.40M | 1.64% | 538,080 | 34.46M |
| 326 | TNXP | Tonix Pharmaceuticals Holding Corp. | 186.43M | -4.82% | 808,442 | 29.10M |
| 327 | NBP | NovaBridge Biosciences | 185.60M | -1.84% | 197,630 | - |
| 328 | DTIL | Precision BioSciences, Inc. | 184.10M | - | 241,366 | 45.06M |
| 329 | CNTN | Canton Strategic Holdings, Inc. | 183.27M | 9.52% | 3,883,592 | 1.50M |
| 330 | NERV | Minerva Neurosciences, Inc. | 174.76M | 5.78% | 815,429 | - |
| 331 | MDWD | MediWound Ltd. | 173.00M | 0.37% | 81,943 | 11.86M |
| 332 | IPHA | Innate Pharma S.A. | 170.18M | -1.05% | 91,437 | 11.21M |
| 333 | MNOV | MediciNova, Inc. | 163.41M | -3.77% | 1,638,805 | 920.48K |
| 334 | HUMA | Humacyte, Inc. | 162.68M | 1.83% | 6,991,145 | 2.12M |
| 335 | MOLN | Molecular Partners AG | 160.97M | 7.40% | 2,857 | 856.30K |
| 336 | OTLK | Outlook Therapeutics, Inc. | 158.87M | -4.17% | 5,621,989 | -1.16M |
| 337 | ARMP | Armata Pharmaceuticals, Inc. | 155.42M | 1.95% | 160,607 | 5.54M |
| 338 | MENS | Jyong Biotech Ltd. | 154.41M | -0.96% | 19,642 | - |
| 339 | RNA | Atrium Therapeutics, Inc. | 153.10M | -6.38% | 1,034,649 | 35.84M |
| 340 | SPRB | Spruce Biosciences, Inc. | 152.47M | -1.50% | 99,578 | 697.00K |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 152.32M | 1.06% | 4,873,201 | 1.34M |
| 342 | CDXS | Codexis, Inc. | 148.93M | 3.03% | 2,875,788 | 77.68M |
| 343 | KRRO | Korro Bio, Inc. | 147.55M | -15.08% | 763,284 | 2.38M |
| 344 | IMUX | Immunic, Inc. | 144.90M | 2.61% | 403,881 | - |
| 345 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 144.67M | 3.03% | 1,154,868 | - |
| 346 | NRXP | NRx Pharmaceuticals, Inc. | 143.63M | -2.06% | 947,272 | 3.39M |
| 347 | KZIA | Kazia Therapeutics Limited | 142.38M | -4.33% | 169,907 | 1.27M |
| 348 | CNXU | Conexeu Sciences Inc. | 139.91M | -6.42% | 608,416 | - |
| 349 | CRBU | Caribou Biosciences, Inc. | 139.37M | -0.76% | 1,853,972 | 10.04M |
| 350 | NMRA | Neumora Therapeutics, Inc. | 137.16M | -2.67% | 3,882,670 | - |
| 351 | HURA | TuHURA Biosciences, Inc. | 133.83M | 0.48% | 173,951 | - |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 133.71M | 0.63% | 1,109,026 | - |
| 353 | BMEA | Biomea Fusion, Inc. | 132.65M | 2.23% | 1,630,910 | - |
| 354 | MIST | Milestone Pharmaceuticals Inc. | 129.05M | -0.41% | 563,177 | 2.34M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 128.21M | 2.48% | 2,907,373 | 65.34K |
| 356 | ENGN | enGene Therapeutics Inc. | 128.00M | - | 400,977 | - |
| 357 | LENZ | LENZ Therapeutics, Inc. | 127.88M | -1.45% | 735,121 | 21.48M |
| 358 | PMN | ProMIS Neurosciences, Inc. | 125.64M | 4.09% | 24,389 | - |
| 359 | CBUS | Cibus, Inc. | 123.05M | -1.23% | 139,149 | 4.35M |
| 360 | NAUT | Nautilus Biotechnology, Inc. | 122.93M | -0.59% | 1,780,520 | 190.00K |
| 361 | EQ | Equillium, Inc. | 121.74M | 1.59% | 853,467 | 4.39M |
| 362 | RANI | Rani Therapeutics Holdings, Inc. | 120.16M | 1.22% | 386,850 | 4.88M |
| 363 | OKUR | OnKure Therapeutics, Inc. | 119.46M | -0.34% | 223,090 | - |
| 364 | AARD | Aardvark Therapeutics, Inc. | 117.74M | -2.71% | 129,702 | - |
| 365 | TLSA | Tiziana Life Sciences Ltd | 117.10M | -6.64% | 414,826 | - |
| 366 | COYA | Coya Therapeutics, Inc. | 114.71M | 2.73% | 403,455 | 8.02M |
| 367 | GNLX | Genelux Corporation | 113.37M | - | 143,116 | 8.00K |
| 368 | PMVP | PMV Pharmaceuticals, Inc. | 113.27M | 2.74% | 1,178,239 | - |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 112.61M | 1.55% | 1,178,456 | 70.00M |
| 370 | CLLS | Cellectis S.A. | 109.30M | 4.79% | 249,466 | 63.82M |
| 371 | TENX | Tenax Therapeutics, Inc. | 108.84M | 2.15% | 7,081,288 | - |
| 372 | VANI | Vivani Medical, Inc. | 107.34M | -1.65% | 904,307 | - |
| 373 | CRDF | Cardiff Oncology, Inc. | 106.58M | 5.38% | 742,258 | 508.00K |
| 374 | PYPD | PolyPid Ltd. | 105.82M | 3.58% | 66,180 | - |
| 375 | SEER | Seer, Inc. | 102.99M | -3.12% | 533,341 | 14.22M |
| 376 | PLYX | Polaryx Therapeutics, Inc. | 101.69M | -4.67% | 81,442 | - |
| 377 | CGTX | Cognition Therapeutics, Inc. | 98.90M | -1.89% | 336,696 | - |
| 378 | NTRB | Nutriband Inc. | 98.83M | 6.27% | 110,506 | 1.62M |
| 379 | ACET | Adicet Bio, Inc. | 98.82M | 1.89% | 114,114 | - |
| 380 | ONCY | Oncolytics Biotech Inc. | 98.18M | - | 491,728 | - |
| 381 | ATRA | Atara Biotherapeutics, Inc. | 97.27M | -0.21% | 37,766 | 6.19M |
| 382 | ANIX | Anixa Biosciences, Inc. | 96.30M | 0.36% | 315,178 | - |
| 383 | NRXS | NeurAxis, Inc. | 95.56M | -0.26% | 174,633 | 5.32M |
| 384 | GUTS | Fractyl Health, Inc. | 95.51M | 1.56% | 1,822,723 | 3.00K |
| 385 | RLYB | Rallybio Corporation | 91.13M | - | 3,350 | 646.00K |
| 386 | ICCC | ImmuCell Corporation | 90.37M | -0.30% | 10,035 | 30.68M |
| 387 | PTHS | Pelthos Therapeutics Inc. | 86.71M | 1.21% | 33,749 | 43.30M |
| 388 | BSEM | BioStem Technologies, Inc. | 84.61M | 8.72% | 857,052 | 34.59M |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 84.59M | 9.82% | 482,021 | - |
| 390 | FBIO | Fortress Biotech, Inc. | 83.71M | - | 414,657 | 68.47M |
| 391 | IBIO | iBio, Inc. | 82.31M | 2.40% | 445,357 | 100.00K |
| 392 | ALDX | Aldeyra Therapeutics, Inc. | 82.04M | -1.45% | 367,724 | - |
| 393 | OSTX | OS Therapies Incorporated | 81.64M | -3.28% | 908,579 | - |
| 394 | NTHI | NeOnc Technologies Holdings, Inc. | 81.03M | -4.40% | 419,324 | 39.99K |
| 395 | CNTB | Connect Biopharma Holdings Limited | 80.61M | -0.78% | 1,282,861 | 2.95M |
| 396 | MAIA | MAIA Biotechnology, Inc. | 79.68M | -6.43% | 468,257 | - |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 79.28M | 8.82% | 478,186 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 76.81M | -1.12% | 375,549 | - |
| 399 | VRCA | Verrica Pharmaceuticals Inc. | 76.45M | -4.30% | 113,529 | 30.32M |
| 400 | RNXT | RenovoRx, Inc. | 76.27M | -2.31% | 565,494 | 1.98M |
| 401 | CING | Cingulate Inc. | 76.20M | 1.75% | 83,187 | - |
| 402 | KLRS | Kalaris Therapeutics, Inc. | 76.18M | 1.27% | 234,394 | - |
| 403 | CSBR | Champions Oncology, Inc. | 73.77M | 4.33% | 28,871 | 60.66M |
| 404 | OKYO | OKYO Pharma Limited | 71.37M | 3.03% | 22,107 | - |
| 405 | ATHE | Alterity Therapeutics Limited | 70.60M | 4.27% | 3,088 | 2.50M |
| 406 | ELOX | Eloxx Pharmaceuticals, Inc. | 70.44M | -0.57% | 66,530 | - |
| 407 | RNTX | Rein Therapeutics Inc. | 69.01M | 1.37% | 477,154 | - |
| 408 | PLRX | Pliant Therapeutics, Inc. | 68.73M | -1.77% | 435,513 | - |
| 409 | XBIT | XBiotech Inc. | 66.77M | 0.46% | 66,090 | - |
| 410 | ALPS | Alps Group Inc | 66.53M | -0.03% | 42,936 | 3.74M |
| 411 | SPRO | Spero Therapeutics, Inc. | 65.81M | 0.89% | 498,102 | 47.00M |
| 412 | GOSS | Gossamer Bio, Inc. | 65.57M | -10.13% | 530,085 | 53.29M |
| 413 | INMB | INmune Bio Inc. | 64.67M | 6.88% | 677,640 | 50.00K |
| 414 | LONA | LeonaBio, Inc. | 63.97M | -2.30% | 52,314 | - |
| 415 | BOLD | Boundless Bio, Inc. | 63.92M | 0.36% | 346,378 | - |
| 416 | HYFT | MindWalk Holdings Corp. | 63.90M | 3.82% | 287,344 | 11.57M |
| 417 | IBO | Impact BioMedical Inc. | 63.61M | 3.26% | 97,645 | 35.00K |
| 418 | INKT | MiNK Therapeutics, Inc. | 61.49M | 2.90% | 18,907 | - |
| 419 | HYPD | Hyperion DeFi, Inc. | 60.91M | 12.97% | 1,158,530 | 1.40M |
| 420 | XLO | Xilio Therapeutics, Inc. | 59.81M | 0.55% | 22,936 | 64.09M |
| 421 | EXOZ | eXoZymes, Inc. | 59.73M | 3.96% | 16,336 | -700.00 |
| 422 | HRTX | Heron Therapeutics, Inc. | 58.80M | -1.90% | 3,953,137 | 151.18M |
| 423 | DWTX | Dogwood Therapeutics, Inc. | 57.45M | -1.74% | 116,152 | - |
| 424 | SER | Serina Therapeutics, Inc. | 57.15M | 1.35% | 66,085 | 130.00K |
| 425 | EDSA | Edesa Biotech, Inc. | 55.94M | - | 41,394 | - |
| 426 | CLNN | Clene Inc. | 55.89M | 4.82% | 191,431 | 197.00K |
| 427 | IMA | ImageneBio, Inc. | 55.51M | -2.59% | 77,052 | 800.00K |
| 428 | APLM | Apollomics, Inc. | 51.43M | 3.95% | 6,727 | 8.84M |
| 429 | TVGN | Tevogen Inc. | 50.86M | 1.30% | 14,913 | - |
| 430 | ELTX | Elicio Therapeutics, Inc. | 49.67M | 1.34% | 689,736 | - |
| 431 | ANVS | Annovis Bio, Inc. | 48.57M | 3.64% | 681,972 | - |
| 432 | MREO | Mereo BioPharma Group plc | 48.39M | 4.45% | 2,739,780 | 500.00K |
| 433 | TIL | Instil Bio, Inc. | 48.08M | -1.66% | 27,516 | - |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 46.90M | 0.21% | 1,226,688 | 21.00M |
| 435 | PDSB | PDS Biotechnology Corporation | 45.08M | -4.36% | 18,859,678 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.39M | -0.94% | 83,720 | - |
| 437 | KPTI | Karyopharm Therapeutics Inc. | 42.64M | 5.03% | 1,901,075 | 146.62M |
| 438 | MGX | Metagenomi Therapeutics, Inc. | 41.55M | -2.65% | 124,383 | 13.56M |
| 439 | VERU | Veru Inc. | 41.09M | 0.84% | 103,031 | 16.89M |
| 440 | IMMP | Immutep Limited | 39.81M | -9.21% | 576,495 | 13.79M |
| 441 | MCRB | Seres Therapeutics, Inc. | 39.77M | -2.44% | 95,086 | 1.88M |
| 442 | LITS | Lite Strategy, Inc. | 38.45M | 8.65% | 1,044,428 | - |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 38.36M | 2.52% | 146,207 | 35.09M |
| 444 | CELU | Celularity Inc. | 37.92M | 3.15% | 188,397 | 26.55M |
| 445 | BCTX | BriaCell Therapeutics Corp. | 36.81M | -0.24% | 269,922 | - |
| 446 | CRVO | CervoMed Inc. | 36.74M | -4.71% | 180,759 | 331.30K |
| 447 | ATYR | aTyr Pharma, Inc. | 35.61M | -3.59% | 1,268,548 | 190.00K |
| 448 | FLNA | Filana Therapeutics, Inc. | 35.07M | 0.83% | 123,137 | - |
| 449 | CNTX | Context Therapeutics Inc. | 33.82M | -3.99% | 1,209,239 | - |
| 450 | ALGS | Aligos Therapeutics, Inc. | 32.72M | 1.35% | 21,340 | 31.52M |
| 451 | NNVC | NanoViricides, Inc. | 32.35M | 1.43% | 696,911 | - |
| 452 | BYSI | BeyondSpring Inc. | 30.83M | 5.78% | 44,206 | 1.88M |
| 453 | ABVC | ABVC BioPharma, Inc. | 30.07M | 0.87% | 199,552 | 797.92K |
| 454 | QNCX | Quince Therapeutics, Inc. | 29.98M | 9.14% | 48,824 | - |
| 455 | QNTM | Quantum BioPharma Ltd. | 29.60M | -1.61% | 94,392 | - |
| 456 | IGC | IGC Pharma, Inc. | 29.46M | 6.98% | 811,702 | 1.11M |
| 457 | CVM | CEL-SCI Corporation | 29.20M | 11.41% | 270,343 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 28.65M | -0.35% | 79,876 | 4.62M |
| 459 | NXTC | NextCure, Inc. | 28.01M | 7.94% | 103,911 | - |
| 460 | RNAZ | TransCode Therapeutics, Inc. | 27.94M | -4.07% | 30,776 | - |
| 461 | EVAX | Evaxion A/S | 27.27M | 1.55% | 43,313 | 7.49M |
| 462 | PBM | Psyence Biomedical Ltd. | 25.27M | 4.83% | 134,675 | - |
| 463 | RADX | Radiopharm Theranostics Limited | 24.67M | -4.62% | 36,841 | 9.34M |
| 464 | ACTU | Actuate Therapeutics, Inc. | 23.56M | -1.41% | 114,376 | - |
| 465 | COCP | Cocrystal Pharma, Inc. | 23.31M | 6.14% | 176,481 | 330.00K |
| 466 | PLRZ | Polyrizon Ltd. | 23.13M | -0.36% | 31,910 | - |
| 467 | ESLA | Estrella Immunopharma, Inc. | 23.01M | 0.57% | 57,686 | - |
| 468 | CLRB | Cellectar Biosciences, Inc. | 22.59M | -0.42% | 73,537 | - |
| 469 | ATOS | Atossa Therapeutics, Inc. | 22.15M | -7.50% | 39,755 | - |
| 470 | GRDX | GridAI Technologies Corp. | 22.02M | 2.98% | 106,125 | - |
| 471 | TVRD | Tvardi Therapeutics, Inc. | 21.74M | 0.62% | 121,534 | - |
| 472 | TCRX | TScan Therapeutics, Inc. | 21.14M | -6.48% | 1,143,331 | 7.11M |
| 473 | JSPR | Jasper Therapeutics, Inc. | 20.56M | -2.57% | 222,807 | - |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 20.00M | -0.40% | 21,578 | 1.17M |
| 475 | LTRN | Lantern Pharma Inc. | 19.82M | -9.36% | 190,483 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 19.67M | 0.85% | 43,237 | 3.55M |
| 477 | ALLR | Allarity Therapeutics, Inc. | 19.25M | 4.31% | 186,589 | 345.00K |
| 478 | PTN | Palatin Technologies, Inc. | 19.02M | 4.12% | 50,768 | 12.88M |
| 479 | CMMB | Chemomab Therapeutics Ltd. | 18.91M | -6.79% | 175,827 | - |
| 480 | NCEL | NewcelX Ltd. | 18.19M | -6.80% | 2,505 | - |
| 481 | AKTX | Akari Therapeutics, Plc | 17.83M | -7.29% | 63,620 | - |
| 482 | BCDA | BioCardia, Inc. | 17.71M | 5.41% | 170,734 | 3.00K |
| 483 | KPRX | Kiora Pharmaceuticals, Inc. | 17.56M | 3.37% | 49,907 | 20.00K |
| 484 | LPCN | Lipocine Inc. | 17.56M | -4.05% | 48,485 | 1.57M |
| 485 | KTTA | Pasithea Therapeutics Corp. | 17.50M | 3.36% | 483,326 | - |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 16.47M | 2.06% | 284,088 | 7.11M |
| 487 | TPST | Tempest Therapeutics, Inc. | 16.01M | 8.16% | 4,799,040 | - |
| 488 | ICU | SeaStar Medical Holding Corporation | 15.60M | 1.23% | 77,702 | 1.71M |
| 489 | CNSY | Cerenome, Inc. | 15.41M | - | 60,179 | 4.20M |
| 490 | LSTA | Lisata Therapeutics, Inc. | 15.32M | -2.30% | 293,907 | 100.00K |
| 491 | PASG | Passage Bio, Inc. | 15.28M | -5.75% | 21,237 | - |
| 492 | DYAI | Dyadic International, Inc. | 15.12M | -2.05% | 281,692 | 3.80M |
| 493 | MBRX | Moleculin Biotech, Inc. | 15.06M | -0.88% | 466,344 | - |
| 494 | HIND | Vyome Holdings, Inc. | 14.74M | 7.14% | 199,471 | 129.73K |
| 495 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.18M | 0.71% | 15,621 | - |
| 496 | ENLV | Enlivex Ltd. | 14.10M | 10.92% | 350,079 | - |
| 497 | NIKI | Niki BioSolutions, Inc. | 13.87M | -10.27% | 137,012 | - |
| 498 | INTS | Intensity Therapeutics, Inc. | 13.42M | 5.93% | 45,213 | - |
| 499 | PLUR | Pluri Inc. | 13.33M | - | 23,831 | 1.02M |
| 500 | CALC | CalciMedica, Inc. | 13.11M | -2.54% | 60,237 | - |